A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement
- 19 August 1993
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 329 (8) , 524-529
- https://doi.org/10.1056/nejm199308193290802
Abstract
Despite the use of warfarin, major systemic embolism remains an important complication in patients with heart-valve replacement. Although the addition of antiplatelet agents has the potential to reduce this complication, their efficacy and safety when given in combination with warfarin are uncertain.Keywords
This publication has 22 references indexed in Scilit:
- The Effect of Warfarin on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1990
- Guidelines on oral anticoagulation: second edition. British Society for Haematology. British Committee for Standards in Haematology. Haemostasis and Thrombosis Task Force.Journal of Clinical Pathology, 1990
- Trial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart ValvesNew England Journal of Medicine, 1990
- RANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENTThe Lancet, 1988
- Prevention of Thromboembolism Induced by Prosthetic Heart ValvesSeminars in Thrombosis and Hemostasis, 1988
- A DOSE‐RANGING STUDY OF THE ANTIPLATELET EFFECT OF ENTERIC COATED ASPIRIN IN MANAustralian and New Zealand Journal of Medicine, 1987
- Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamoleThe American Journal of Cardiology, 1983
- Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1982
- Prevention of arterial thromboembolism with acetylsalicylic acidAmerican Heart Journal, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958